Endocan is a reliable biomarker during continuous renal replacement therapy

Maxence Hureau; Alexandre Gaudet; Nathalie De Freitas Caires; Erika Parmentier; Julien Poissy; Thibault Duburcq; Philippe Lassalle; Daniel Mathieu

doi:10.1186/s13054-019-2585-4

Endocan is a reliable biomarker during continuous renal replacement therapy

Crit Care. 2019 Sep 3;23(1):296. doi: 10.1186/s13054-019-2585-4.

Authors

Maxence Hureau^{1

2

3

4}, Alexandre Gaudet^{5

6

7

8}, Nathalie De Freitas Caires^{5

6

7

9}, Erika Parmentier^{5

6

7

8}, Julien Poissy⁸, Thibault Duburcq⁸, Philippe Lassalle^{5

6

7

10}, Daniel Mathieu^{5

6

7

8}

Affiliations

¹ University Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France. maxence.hureau@gmail.com.
² CNRS, UMR 8204, F-59000, Lille, France. maxence.hureau@gmail.com.
³ INSERM, U1019, F-59000, Lille, France. maxence.hureau@gmail.com.
⁴ CHU Lille, Pôle de Réanimation, Hôpital Roger Salengro, F-59000, Lille, France. maxence.hureau@gmail.com.
⁵ University Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France.
⁶ CNRS, UMR 8204, F-59000, Lille, France.
⁷ INSERM, U1019, F-59000, Lille, France.
⁸ CHU Lille, Pôle de Réanimation, Hôpital Roger Salengro, F-59000, Lille, France.
⁹ Lunginnov, 1 rue du Pr Calmette, F-59000, Lille, France.
¹⁰ Institut Pasteur de Lille, F-59000, Lille, France.

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Humans
Pneumonia*
Renal Replacement Therapy
Respiratory Distress Syndrome*
Sepsis*

Substances

Biomarkers